News
AFIB
0.1668
-1.24%
-0.0021
Weekly Report: what happened at AFIB last week (0415-0419)?
Weekly Report · 2d ago
Earlier Announced, Acutus Medical Was Granted EU Patent #3294412 For "Localization System And Method Useful In The Acquisition And Analysis Of Cardiac Information".
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Trevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. Mustang Bio stock increased by 11.97% and SINTX Techs stock rose 10.32% in the same session. Losers TRACON Pharma and DIH Holding US stock fell by 16.6% and 14.05% respectively.
Benzinga · 04/17 20:31
Weekly Report: what happened at AFIB last week (0408-0412)?
Weekly Report · 04/15 09:21
Weekly Report: what happened at AFIB last week (0401-0405)?
Weekly Report · 04/08 09:22
Acutus Medical, Inc.: Annual report
Press release · 04/02 02:38
Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M
Acutus Medical reports FY GAAP EPS of -$2.81, revenue of $7.2M (+140.0% Y/Y). The company will exit from the electrophysiology mapping and ablation businesses. The company is expected to report Q1 results on April 1.
Seeking Alpha · 04/01 20:47
*Acutus Medical 4Q Rev $2.4M >AFIB
Dow Jones · 04/01 20:12
*Acutus Medical: Due to Plan to Realign Resources to Support Left-Heart Access Distribution Business and Exit From Electrophysiology Mapping and Ablation Businesses, Co Will No Longer Provide Fincl Guidance >AFIB
Dow Jones · 04/01 20:12
ACUTUS MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Reuters · 04/01 20:05
ACUTUS MEDICAL INC - WILL NO LONGER PROVIDE FINANCIAL GUIDANCE
Reuters · 04/01 20:05
Press Release: Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
Acutus Medical reports Fourth Quarter and Full Year 2023 Financial Results. The company is focused on the production of left-heart access products under its distribution agreement with Medtronic. The Company announced a strategic realignment of resources and corporate restructuring on November 8, 2023. Full year revenue from continuing operations grew 136% year-over-year.
Dow Jones · 04/01 20:05
Press Release: Acutus Medical Reports Fourth -2-
Total liabilities and stockholders' equity for Acutus Medical, Inc. The company has a total of 75,000,000 shares of equity. The company expects to have a net loss for the year ending December 31, 2022. The Company has no debt and no debt obligations.
Dow Jones · 04/01 20:05
Weekly Report: what happened at AFIB last week (0325-0329)?
Weekly Report · 04/01 09:21
Weekly Report: what happened at AFIB last week (0318-0322)?
Weekly Report · 03/25 09:22
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. Fell sharply after the company reported worse-than-expected fourth-quarter EPS results. Ontrak, Inc. Shares climbed 197.8% to $0.5660 in Tuesday's mid-day session. Fusion Pharmaceuticals Inc. Gained 97.3% after agreeing to be acquired by AstraZeneca.
Benzinga · 03/19 17:48
12 Health Care Stocks Moving In Tuesday's Intraday Session
Ontrak (NASDAQ:OTRK) shares increased by 97.6% to $0.38 during Tuesday's regular session. Fusion Pharmaceuticals stock moved upwards by 97%. SCWorx stock rose 70.74% and Enliven Therapeutics stock increased by 29.19%. Acutus Medical stock declined by 26.5% during the session.
Benzinga · 03/19 17:31
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ontrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. Fusion Pharmaceuticals and Enveric Biosciences moved upwards by 97.46% and 39.09% respectively. Losers include Seelos Therapeutics and Acurx Pharmaceuticals.
Benzinga · 03/19 13:05
Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket
Shares of Fusion Pharmaceuticals Inc. Rose sharply in today's pre-market trading. The company agreed to be acquired by AstraZeneca for around $2 billion in cash. Ontrak, Inc. Shares rose 84.2% to $0.35 in pre- market trading.
Benzinga · 03/19 12:10
12 Health Care Stocks Moving In Monday's After-Market Session
Ontrak (NASDAQ:OTRK) stock increased by 61.0% to $0.31 during Monday's after-market session. Universe Pharmaceuticals (NASdaq:UPC) shares rose 30.26% in the same session. Augmedix and Sophia Genetics also moved upwards. Losers Acurx Pharmaceuticals, Acutus Medical and Fresh2 Group were among the names in the losers.
Benzinga · 03/18 21:33
More
Webull provides a variety of real-time AFIB stock news. You can receive the latest news about Acutus Medical, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About AFIB
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.